Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Zealand Pharma
  4. Zealand Pharma — Marts 2022

Zealand Pharma — Marts 2022

Planlagt Fastgjort Låst Flyttet Zealand Pharma
248 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • D Offline
    D Offline
    deleted-user
    wrote on sidst redigeret af
    #85

    Tænker du er på rette vej LP90 med den vurdering 🙂

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #86

      Ja, vel nogle shortpositioner som lukkes?!

      Men det tæller er velsagtens at der er betydelig fremgang i pipelinen med nøgledata for Glepaglutid og Dasiglucagon her i 2022 🙂

      1 Reply Last reply
      0
      • D Offline
        D Offline
        deleted-user
        wrote on sidst redigeret af
        #87

        Adam Steensberg er nok ikke ked af sit salg tilbage i september 2021 i kurs +200....

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #88

          ... det der tæller ...

          1 Reply Last reply
          0
          • DeltaFlyerD Offline
            DeltaFlyerD Offline
            DeltaFlyer
            wrote on sidst redigeret af
            #89

            Den falder vel ikke 13% ved at nogle lukker deres short

            1 Reply Last reply
            0
            • D Offline
              D Offline
              deleted-user
              wrote on sidst redigeret af
              #90

              Enig Exit - resultaterne de kommende 6 måneder, men det står sløjt til med kapitalen. Emission er no go i nuværende kurs og lånefinaniseret drift, er en dårlig spiral, at have i
              .

              1 Reply Last reply
              0
              • D Offline
                D Offline
                deleted-user
                wrote on sidst redigeret af
                #91

                @DeltaFlyver - måske 🙂 Du tror jo også, at markedet reagerer med 18 timers forsinkelse, så hvem ved 😉

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #92

                  @DeltaFlyer - ikke mange shorts de lukkes lige nu (lav omsætning) men de kan lige så godt få statet op på det umulige projekt.

                  1 Reply Last reply
                  0
                  • exitnuE Offline
                    exitnuE Offline
                    exitnu
                    wrote on sidst redigeret af
                    #93

                    lukker

                    1 Reply Last reply
                    0
                    • Cubinvest2021C Offline
                      Cubinvest2021C Offline
                      Cubinvest2021
                      wrote on sidst redigeret af
                      #94

                      Nordea gentager sin købsanbefaling med kursmål 234 i dag: Zealand Pharma (Zealand) reported overall 2021 numbers in line with expectations but with Zegalogue sales of DKK 5.5m continuing to miss estimates. For 2022, Zealand is guiding for product sales of DKK 235m, +/-10%, which was also below our expectations. We once again cut our Zegalogue estimates to reflect a slower than expected uptake curve and our DCF-derived target price is lowered to DKK 234 (254). We remain buyers of the stock as we

                      1 Reply Last reply
                      0
                      • Cubinvest2021C Offline
                        Cubinvest2021C Offline
                        Cubinvest2021
                        wrote on sidst redigeret af
                        #95

                        (...) continue to believe that Zealand is undervalued based on its late-stage pipeline, but we acknowledge that the stock will likely remain depressed and range-bound until its high-impact pipeline data materialises – in particular the ph III glepaglutide data in SBS during Q3 2022

                        1 Reply Last reply
                        0
                        • exitnuE Offline
                          exitnuE Offline
                          exitnu
                          wrote on sidst redigeret af
                          #96

                          @Cubinvest2021 - tak!

                          1 Reply Last reply
                          0
                          • Cubinvest2021C Offline
                            Cubinvest2021C Offline
                            Cubinvest2021
                            wrote on sidst redigeret af
                            #97

                            Så er vi tilbage i samme kurs som for 4 år siden... SUK

                            1 Reply Last reply
                            0
                            • M Offline
                              M Offline
                              Munchi
                              wrote on sidst redigeret af
                              #98

                              har svært ved at forstå hvorfor folk tror at e aktie falder når lukkes shorts ?

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                Munchi
                                wrote on sidst redigeret af
                                #99

                                mit bud er at der i dag med god grund bliver mast 1% nye shorts ind... og derfor går vi i gulvet

                                1 Reply Last reply
                                0
                                • Cubinvest2021C Offline
                                  Cubinvest2021C Offline
                                  Cubinvest2021
                                  wrote on sidst redigeret af
                                  #100

                                  De professionelle shortere kan sagtens presse kursen ned for at aktivere stop loss og købe i bunden, men det her ligner mere øgede shortpositioner

                                  1 Reply Last reply
                                  0
                                  • exitnuE Offline
                                    exitnuE Offline
                                    exitnu
                                    wrote on sidst redigeret af
                                    #101

                                    "Needham & Company Reiterates Zealand Pharma (ZEAL) at Buy, Short Bowel Syndrome Program Remains Main Value Driver"
                                    "Needham & Company analyst Joseph Stringer reiterated a Buy rating and $42.00 price target on Zealand Pharma A/S (NASDAQ: ZEAL) .."

                                    Svarer til kurs DKK 284,-

                                    1 Reply Last reply
                                    0
                                    • exitnuE Offline
                                      exitnuE Offline
                                      exitnu
                                      wrote on sidst redigeret af
                                      #102

                                      Joseph Stringer var med på CC igår!

                                      "Conference Call Participants: Joseph Stringer - Needham & Company, LLC"

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        ProinvestorNEWS
                                        wrote on sidst redigeret af
                                        #103

                                        Zealand Pharma/Nordea: Sænker kursmål med en tyver https://proinvestor.com/investornyt/794047/zealand-pharma-nordea-saenker-kursmal-med-en-tyver

                                        1 Reply Last reply
                                        0
                                        • exitnuE Offline
                                          exitnuE Offline
                                          exitnu
                                          wrote on sidst redigeret af
                                          #104

                                          "Nordea sætter kurmålet for en aktie i Zealand Pharma ned til 234 kr. fra 254 kr. og gentager sin købsanbefaling."

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper